why choose us

First received: July 14, 2022

Clinical Trial: Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: COVID-19
SARS-CoV-2 Infection

Study Type: Interventional


Official Title: A Randomized, Observer-Blinded, Phase 3 Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults

Brief Summary: This is a randomized, Phase 3 study comparing the immunogenicity and safety of 3 different lots of Novavax vaccine with Matrix-M™ adjuvant (NVX-CoV2373).The study will enroll approximately 900 previously vaccinated adults 18 to 49 years of age, inclusive.

Read more